Brez internetne povezave — prikazana je shranjena različica strani.

ABBOTT LABORATORI…

USUSD
← Na Filter Delnic

ABBOTT LABORATORIES (XETRA:ABL) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 4. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
abbott.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
North Chicago, United States
Izvršni Direktor
Robert Ford
Zaposleni
73 000
Ustanovljena
1888
Na Borzi od
20.12.2007 (XETRA:ABL)
Delnice v Obtoku
1.73 mrd. na dan 2026-06-30
Prosto Prenosljive Delnice
1.72 mrd.
Tržna Kapitalizacija
169.83 mrd. USD
Notranje Osebe
0.49%
Institucionalni Vlagatelji
81.79%
Panoga (SIC)
Pharmaceutical Preparations
Pravna Oblika
AZUK
ISIN
US0028241000
LEI
HQD377W2YR662HK5JX27
P/E
33.4
Delež Izplačila
66.7%
FCF
7.38 mrd. USD
Izplačilo / FCF
57%
Dolg
34.0 mrd. USD
3.7 let FCF
Dividendni Staž
43 let
Dobički, FCF in izplačane dividende — za 12 mesecev do 31.03.2026 (najnovejše poročilo podjetja).
NAV
29.89 USD · P/NAV 3.42
Datum Bilance Stanja31.03.2026
Sredstva110 mrd. USD
− Obveznosti57.7 mrd. USD
= Skupni Kapital52.7 mrd. USD
− Nekontrolni Deleži640 mio. USD
= NAV (lastniški delež delničarjev podjetja)52.1 mrd. USD
− Dobro Ime35.2 mrd. USD
− Neopredmetna Sredstva17.9 mrd. USD
= Opredmetena NAV−1.04 mrd. USD
Delnice1 741 812 429
NAV na Delnico29.89 USD
Otipljiv NAV na Delnico−0.59 USD
Cena Delnice (ABL)88.8600 EUR
P/NAV3.42
Zgodovina NAV
Datum Bilance StanjaNAVNAV na Delnico
31.03.202652.1 mrd. USD29.89 USD
31.12.202552.1 mrd. USD30.00 USD
30.09.202551.0 mrd. USD29.30 USD
30.06.202550.6 mrd. USD29.05 USD
31.03.202548.8 mrd. USD28.05 USD
31.12.202447.7 mrd. USD27.48 USD
30.09.202439.8 mrd. USD22.94 USD
30.06.202439.3 mrd. USD22.60 USD
Opis

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksABT glavnaUSD104.89 +0.20%navadne delnice
LSE London Stock Exchange0Q15 IOBUSD103.27 +4.07%navadne delnice
MX Mexican Stock ExchangeABT dodatnaMXN1 935.4 +2.40%navadne delnice
XETRA XetraABL dodatnaEUR88.86 +2.21%navadne delnice

Cena v 3 Mesecih

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Na leto, XETRA:ABL: 1.6798 EUR (3 izpl.)

ABBOTT LABORATORIES (ABL) izplačuje dividende četrtletno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 1.6798 EUR na delnico (plačila: 3). To je približno 1.89% trenutne cene delnice. Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 13.01.2027. Leta neprekinjenih dividend: 43.

Ex-DatumIzplačiloZnesek%VrstaOznaka
2026-07-15—0.5599 EUR0.7/2.8 %četrtletnoXETRA:ABL
2026-04-15—0.5599 EUR0.6/2.5 %četrtletnoXETRA:ABL
2026-01-15—0.5599 EUR0.5/2.0 %četrtletnoXETRA:ABL
2025-10-15—0.5244 EUR0.5/1.8 %četrtletnoXETRA:ABL
2025-07-15—0.5244 EUR0.5/1.8 %četrtletnoXETRA:ABL
2025-04-15—0.5244 EUR0.5/1.8 %četrtletnoXETRA:ABL
2025-01-15—0.5244 EUR0.5/1.8 %četrtletnoXETRA:ABL
2024-10-15—0.4888 EUR0.5/1.8 %četrtletnoXETRA:ABL
2024-07-15—0.4888 EUR0.5/2.0 %četrtletnoXETRA:ABL
2024-04-12—0.4888 EUR0.5/1.8 %četrtletnoXETRA:ABL
2024-01-11—0.4888 EUR0.5/1.8 %četrtletnoXETRA:ABL
2023-10-12—0.4533 EUR0.5/2.0 %četrtletnoXETRA:ABL
2023-07-13—0.4533 EUR0.5/1.8 %četrtletnoXETRA:ABL
2023-04-13—0.4533 EUR0.5/1.9 %četrtletnoXETRA:ABL
2023-01-12—0.4533 EUR0.4/1.6 %četrtletnoXETRA:ABL
2022-10-13—0.4177 EUR0.4/1.6 %četrtletnoXETRA:ABL
2022-07-14—0.4177 EUR0.4/1.2 %četrtletnoXETRA:ABL
2022-04-13—0.4177 EUR0.4/0.8 %četrtletnoXETRA:ABL
2022-01-13—0.4177 EUR0.4/0.4 %četrtletnoXETRA:ABL

Novice Ta Teden

Sporočila za javnost s spletne strani za vlagatelje podjetja, ki se dnevno posodabljajo. Povezave vodijo na spletno stran podjetja. Naslovi so v izvirnem jeziku, kot na spletni strani podjetja.

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
BlackRock8.82%152.56 mio.2026-06-30
Vanguard Capital Managem…6.57%113.75 mio.2026-06-30
State Street Corporation4.68%80.93 mio.2026-06-30
Charles Schwab Investmen…3.45%59.67 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.2%55.3 mio.2026-06-30
Vanguard Portfolio Manag…2.83%49.02 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.61%45.14 mio.2026-06-30
Geode Capital Management…2.27%39.22 mio.2026-06-30
Capital Research Global…2.13%36.91 mio.2026-06-30
Capital International In…2%34.65 mio.2026-06-30
SCHWAB STRATEGIC TRUST-S…1.9%32.82 mio.2026-05-31
Morgan Stanley1.54%26.61 mio.2026-06-30
NORGES BANK1.35%23.35 mio.2026-06-30
iShares Trust-iShares Co…1.34%23.2 mio.2026-08-31
Fidelity Concord Street…1.3%22.52 mio.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%21.31 mio.2026-08-31
WASHINGTON MUTUAL INVEST…1.01%17.53 mio.2026-07-31
VANGUARD INDEX FUNDS-Van…0.96%16.58 mio.2026-06-30
SELECT SECTOR SPDR TRT-S…0.72%12.52 mio.2026-08-31
Investment Co of America0.6%10.33 mio.2026-06-30
STARKS DANIEL J (Directo…≈0.39%6.75 mio.2026-04-27
FORD ROBERT B. (Chief Ex…≈0.03%522 6642026-08-25
ALLEN HUBERT L. (Officer…≈0.01%200 2812025-02-25
SALVADORI DANIEL GESUA S…≈0.01%146 3772026-03-02
CONROY KEVIN T (Director…≈0.01%133 7372026-04-24
MORELAND MARY K (Officer…≈0.01%116 1362026-03-02
EARNHARDT LISA D (Office…≈0.01%98 9842026-02-24
SCOGGINS CHRISTOPHER J (…≈0%82 1232026-02-24
WAINER ANDREA F (Officer…≈0%74 3812025-03-03
The Vanguard Group———
BOUDREAU PHILIP P (Chief…——2026-04-23